A Precision Medicine Company
Identifying the root cause of neurologic, psychiatric, and behavioral disorders.

The Cunningham Panel is an aid to a physician’s diagnosis of an infection-triggered autoimmune neuropsychiatric disorder.

Revolutionizing the way we look at mental disorders

Leaders in autoimmunity testing for neuropsychiatric illnesses

The Cunningham Panel™ helps clinicians identify whether a patient’s neurologic and/or psychiatric symptoms may be due to an infection-triggered basal ganglia encephalitis (BGE), which includes autoimmune neuropsychiatric syndromes such as PANS/PANDAS. Symptoms of BGE can mimic various mental illnesses.
The Cunningham Panel™ measures the levels of specific autoantibodies that may be attacking receptors as well as other targets in the basal ganglia and their ability to disrupt neuronal functioning. This disruption can affect movement, behavior and cognition.
Check with your doctor as elevated levels can indicate that neuropsychiatric symptoms may be due to BGE (a type of autoimmune encephalitis) rather than a primary psychiatric disorder.
The Cunningham Panel™ measures antibodies attacking the brain causing inflammation and abnormal behaviors

Mental illness, behavioral disorder, or autoimmune encephalitis?

Common infections (i.e., strep, influenza, mycoplasma, Lyme disease, Babesia, Bartonella and coxsackie virus) can trigger autoimmune basal ganglia encephalitis. This condition can cause neurologic, behavioral and psychiatric symptoms which may include OCD, tics, anxiety, depression, and behaviors associated with autism spectrum disorders.

Science That Impacts Lives.

There is a growing body of scientific evidence documenting the connection between infection, inflammation, immune dysfunction and the development of neurologic and psychiatric illnesses. Following is a list of peer-reviewed journal articles by world-renowned researchers and clinicians investigating infection-induced autoimmune neurologic disorders.

Physicians worldwide are using the Cunningham Panel™ to help guide diagnosis and target treatments.

  • Moleculera Labs: Our Mission
    Dr. Craig Shimasaki, president and CEO of Moleculera Labs, discusses the company’s mission to develop and offer advanced testing services that will help clinicians identify autoimmune-induced neuropsychiatric conditions.
  • Autoimmunity testing with the Cunningham Panel™
    Dr. Madeleine Cunningham explains how the Cunningham Panel™ can assist in determining whether an autoimmune process may be causing a person’s neurologic and/or psychiatric symptoms.
  • testimonial Wendy
    “My son began having symptoms of ADHD and autism. He had severe social anxiety and fits of rage. The doctors didn’t have an answer. He had a history of strep infections and eventually a psychiatrist suspected he had PANDAS. The Cunningham Panel™ test results confirmed the diagnosis and helped the doctor develop a treatment plan. The test gave us piece of mind that we finally had the right answer.”
      Wendy
    The Cunningham Panel™ can help identify the level of autoimmune antibodies associated with Neuropsychiatric Disorders
  • testimonial Martha
    “I am so thankful to have had the Cunningham Panel™ to confirm my daughter’s PANDAS diagnosis. Your nurse hit the nail on the head when she pointed out that one of her high markers can be associated with anger. That is the first thing we notice when she begins to flare, and no one else ever made this connection. We are so appreciative to have quantifiable results because we second-guessed ourselves so many times, and now we know it's not just our imagination, bad parenting or some kind of hidden psychiatric illness. Thank you so much for giving us hope!”
     Martha
    The Cunningham Panel™ can help identify the level of autoimmune antibodies associated with Neuropsychiatric Disorders
  • testimonial Lori
    “We had the Cunningham Panel™ test done on my daughter. She had OCD, separation anxiety and tics but also a lot of physical discomfort from joint pain and muscle aches. She was in treatment but never got completely well. The test results confirmed she had an autoimmune problem. I am so grateful we had a test that could help us figure out the diagnosis and determine the best treatment plan.”
     Lori
    The Cunningham Panel™ can help identify the level of autoimmune antibodies associated with Neuropsychiatric Disorders

PIONEERING RESEARCH. LIFE-CHANGING TESTS
Remarkable results happen here.

Infection-triggered autoimmune disorders, such as PANS/PANDAS, which cause neuropsychiatric symptoms can be difficult to recognize. The following videos provide insight into the complexity of these disorders and demonstrate how the Cunningham Panel™ can assist physicians.
HEALTHCARE PROVIDERS: REQUEST A PERSONAL CONSULTATION

SIGNUP FOR EDUCATIONAL SERIES

  • Please tell us about yourself so we can send you the appropriate updates on Neuropsychiatric Disorders testing and research.